“…[1][2][3][4][5][6][8][9][10][11] Among these 9 studies, 3 were conducted in middle-aged or older cancer survivors, 3,4,6,9 4 studies were conducted in other subgroups of older adults (healthy older adults, and older adults with insomnia, depression, or mild cognitive impairment), 2,5,8,11 1 study was conducted in HIV-infected adults, 1 and 1 study was conducted in women with elevated cardiovascular disease risk. 10 All studies, except for 1, 10 included an active control group that received health education, cognitive behavioral therapy, or other interventions. The terms ranged from 3 weeks to 6 months, and the doses varied as the duration ranged from 1 to 2 h and the frequency ranged from one time per week to three times per week.…”